HGERS
BRTX icon

Householder Group Estate & Retirement Specialist’s BioRestorative Therapies BRTX Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$1K Hold
200
– – ﹤0.01% 1129
2022
Q4 		$0 Hold
200
– – ﹤0.01% 417
2022
Q3 		$0 Buy
+200
New +$621 ﹤0.01% 1093

Other funds holding BRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's BRTX Position: Q1 2023 in Review

Householder Group Estate & Retirement Specialist held its BioRestorative Therapies (BRTX) position steady in Q1 2023 at 200 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

Householder Group Estate & Retirement Specialist first reported a position in BRTX in Q3 2022 and has held it in 3 quarters since. 14 funds tracked by Wall St. Rank hold BRTX as of Q1 2023.

  • Householder Group Estate & Retirement Specialist held 200 shares of BioRestorative Therapies worth $1K as of Q1 2023.
  • Householder Group Estate & Retirement Specialist left its BioRestorative Therapies share count unchanged in Q1 2023.
  • BioRestorative Therapies made up ﹤0.01% of Householder Group Estate & Retirement Specialist's portfolio in Q1 2023, its #1129 holding.
  • Householder Group Estate & Retirement Specialist first reported a position in BioRestorative Therapies in Q3 2022 and has held it in 3 quarters since.
  • 14 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q1 2023.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q1 2023, filed 13 Apr 2023.